切换至 "中华医学电子期刊资源库"

中华乳腺病杂志(电子版) ›› 2015, Vol. 09 ›› Issue (06) : 394 -397. doi: 10.3877/cma. j. issn.1674-0807.2015.06.009

综述

肿瘤相关基质金属蛋白酶在乳腺癌中的研究进展
黄红颜1, 谭金祥1,(), 任国胜1   
  1. 1.400016 重庆医科大学第一附属医院内分泌乳腺外科
  • 收稿日期:2015-07-16 出版日期:2015-12-01
  • 通信作者: 谭金祥
  • 基金资助:
    国家自然科学基金资助项目(81102008)

Recent research advance on cancer-associated matrix metalloproteinases in breast cancer

Hongyan Huang, Jinxiang Tan(), Guosheng Ren   

  • Received:2015-07-16 Published:2015-12-01
  • Corresponding author: Jinxiang Tan
引用本文:

黄红颜, 谭金祥, 任国胜. 肿瘤相关基质金属蛋白酶在乳腺癌中的研究进展[J/OL]. 中华乳腺病杂志(电子版), 2015, 09(06): 394-397.

Hongyan Huang, Jinxiang Tan, Guosheng Ren. Recent research advance on cancer-associated matrix metalloproteinases in breast cancer[J/OL]. Chinese Journal of Breast Disease(Electronic Edition), 2015, 09(06): 394-397.

[1]
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015[J].CA Cancer J Clin,2015,65(1):5-29.
[2]
DeSantis C, Ma J, Bryan L, et al. Breast cancer statistics,2013[J]. CA Cancer J Clin,2014,64(1):52-62.
[3]
Kessenbrock K, Plaks V, Werb Z. Matrix metalloproteinases:regulators of the tumor microenvironment[J]. Cell, 2010,141(1):52-67.
[4]
Murphy G, Nagase H. Progress in matrix metalloproteinase research[J]. Mol Aspects Med,2008,29(5):290-308.
[5]
Takeuchi T, Adachi Y, Nagayama T, et al. Matrix metalloproteinase-11 overexpressed in lobular carcinoma cells of the breast promotes anoikis resistance[J]. Virchows Arch,2011,459(3):291-297.
[6]
Wu QW, Yang QM, Huang YF, et al. Expression and clinical significance of matrix metalloproteinase-9 in lymphatic invasiveness and metastasis of breast cancer[J]. PLoS One,2014,9(5):e97804.
[7]
Cathcart J, Pulkoski-Gross A, Cao J. Targeting matrix metalloproteinases in cancer:bringing new life to old ideas[J].Genes Dis,2015,2(1):26-34.
[8]
Gialeli C, Theocharis AD, Karamanos NK. Roles of matrix metalloproteinases in cancer progressionandtheir pharmacological targeting[J]. FEBS J,2011,278(1):16-27.
[9]
Mu H, Wang N, Zhao L, et al. Methylation of PLCD1 and adenovirus-mediated PLCD1 overexpression elicits a gene therapy effect on human breast cancer[J]. Exp Cell Res,2015,332(2):179-189.
[10]
Fernández-Guinea O, Álvarez-Cofiño A, Eiró N, et al. Low microvascular density at the tumor center is related to the expression of metalloproteases and their inhibitors and with the occurrence of distant metastasis in breast carcinomas. Int J Clin Oncol,2013,18(4):629-640.
[11]
Davies KJ. The complex interaction of matrix metalloproteinases in the migration of cancer cells through breast tissue stroma[J]. Int J Breast Cancer,2014,2014:839 094.
[12]
Solov'eva NI, Timoshenko OS, Kugaevskaia EV, et al. Key enzymes of degradation and angiogenesis as a factor of tumor progression in squamous cell carcinoma of the cervix[J].Bioorg Khim,2014,40(6):743-751.
[13]
Ager EI, Kozin SV, Kirkpatrick ND, et al. Blockade of MMP14 activity in murine breast carcinomas: implications for macrophages, vessels, and radiotherapy[J]. J Natl Cancer Inst,2015,107(4):djv017.
[14]
Vinothini G, Aravindraja C, Chitrathara K, et al. Correlation of matrix metalloproteinases and their inhibitors with hypoxia and angiogenesis in premenopausal patients with adenocarcinoma of the breast[J]. Clin Biochem,2011,44(12):969-974.
[15]
Darakhshan S, Bidmeshkipour A, Khazaei M, et al.Synergistic effects of tamoxifen and tranilast on VEGF and MMP-9 regulation in cultured human breast cancer cells[J].Asian Pac J Cancer Prev,2013,14(11):6869-6874.
[16]
Leifler KS, Svensson S, Abrahamsson A, et al. Inflammation induced by MMP-9 enhances tumor regression of experimental breast cancer[J]. J Immunol,2013,190(8):4420-4430.
[17]
Sounni NE,Dehne K,van Kempen L,et al. Stromal regulation of vessel stability by MMP14 and TGFbeta[J]. Dis Model Mech,2010,3(5-6):317-332.
[18]
Ingvarsen S, Porse A, Erpicum C, et al. Targeting a single function of the multifunctional matrix metalloprotease MT1-MMP: impact on lymphangiogenesis[J]. J Biol Chem, 2013,288(15):10 195-10 204.
[19]
Cierna Z,Mego M,Janega P,et al. Matrix metalloproteinase 1 and circulating tumor cells in early breast cancer[J]. BMC Cancer,2014,14:472.
[20]
Wu K, Fukuda K, Xing F, et al. Roles of the cyclooxygenase 2 matrix metalloproteinase 1 pathway in brain metastasis of breast cancer[J]. J Biol Chem,2015,290(15):9842-9854.
[21]
Sendon-Lago J,Seoane S,Eiro N,et al. Cancer progression by breast tumors with Pit-1-overexpression is blocked by inhibition of metalloproteinase (MMP)-13 [J]. Breast Cancer Res,2014,16(6):505.
[22]
Chen Y, Wang X, Chen G, et,al. The impact of matrix metalloproteinase 2 on prognosis and clinicopathology of breast cancer patients: a systematic meta-analysis[J]. PLoS One,2015,10(3):e0121404
[23]
Platt D, Amara S, Mehta T, et al. Violacein inhibits matrix metalloproteinase mediated CXCR4 expression: potential antitumor effect in cancer invasion and metastasis[J]. Biochem Biophys Res Commun,2014,455(1-2):107-112.
[24]
Fernandez-Garcia B, Eiró N, Marín L, et al. Expression and prognosticsignificanceoffibronectinandmatrix metalloproteases in breast cancer metastasis [ J ].Histopathology,2014,64(4):512-522.
[25]
Kwon YJ, Hurst DR, Steg AD, et al. Gli1 enhances migration and invasion via up-regulation of MMP-11 and promotes metastasis in ERαnegative breast cancer cell lines[J]. Clin Exp Metastasis,2011,28(5):437-449.
[26]
Pivetta E, Scapolan M, Pecolo M, et al. MMP-13 stimulates osteoclast differentiation and activation in tumour breast bone metastases[J]. Breast Cancer Res,2011,13(5):R105.
[27]
Vandenbroucke RE,Libert C. Is there new hope for therapeutic matrix metalloproteinase inhibition? [ J]. Nat Rev Drug Discov,2014,13(12):904-927.
[28]
Overall CM. Molecular determinants of metalloproteinase substrate specificity: matrix metalloproteinase substrate binding domains, modules, and exosites[J]. Mol Biotechnol,2002,22(1):51-86.
[29]
Hendry RG, Bilawchuk LM, Marchant DJ. Targeting matrix metalloproteinase activity and expression for the treatment of viral myocarditis[J]. J Cardiovasc Transl Res, 2014,7(2):212-225.
[30]
Chimal-Ramírez GK,Espinoza-Sánchez NA,Utrera-Barillas D,et al. MMP1, MMP9, and COX2 expressions in promonocytes are induced by breast cancer cells and correlate with collagen degradation,transformation-like morphological changes in MCF-10A acini, and tumor aggressiveness[J]. Biomed Res Int,2013,2013:279505.
[31]
Toomer KH, Chen Z. Autoimmunity as a double agent in tumor killing and cancer promotion[J]. Front Immunol,2014,5:116.
[32]
Li Q, Park PW, Wilson CL, et al. Matrilysin shedding of syndecan-1 regulates chemokine mobilization and transepithelial efflux of neutrophils in acute lung injury[J]. Cell,2002,111(5):635-646.
[33]
Tan J, Buache E, Chenard MP, et al. Adipocyte is a nontrivial, dynamic partner of breast cancer cells[J]. Int J Dev Biol,2011,55(7-9):851-859.
[34]
Dirat B, Bochet L, Dabek M, et al. Cancer-associated adipocytes exhibit an activated phenotype and contribute to breast cancer invasion [J]. Cancer Res, 2011,71 (7):2455-2465.
[35]
Nieman KM, Kenny HA, Penicka CV, et al. Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth[J]. Nat Med,2011,17(11):1498-1503.
[36]
Tan J, Buache E, Alpy F, et al. Stromal matrix metalloproteinase-11 is involved in the mammary gland postnatal development[J]. Oncogene,2014,33(31):4050-4059.
[37]
Chun TH, Hotary KB, Sabeh F, et al. A pericellular collagenase directs the 3-dimensional development of white adipose tissue[J]. Cell,2006,125(3):577-591.
[1] 李洋, 蔡金玉, 党晓智, 常婉英, 巨艳, 高毅, 宋宏萍. 基于深度学习的乳腺超声应变弹性图像生成模型的应用研究[J/OL]. 中华医学超声杂志(电子版), 2024, 21(06): 563-570.
[2] 河北省抗癌协会乳腺癌专业委员会护理协作组. 乳腺癌中心静脉通路护理管理专家共识[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 321-329.
[3] 刘晨鹭, 刘洁, 张帆, 严彩英, 陈倩, 陈双庆. 增强MRI 影像组学特征生境分析在预测乳腺癌HER-2 表达状态中的应用[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 339-345.
[4] 张晓宇, 殷雨来, 张银旭. 阿帕替尼联合新辅助化疗对三阴性乳腺癌的疗效及预后分析[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 346-352.
[5] 邱琳, 刘锦辉, 组木热提·吐尔洪, 马悦心, 冷晓玲. 超声影像组学对致密型乳腺背景中非肿块型乳腺癌的诊断价值[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 353-360.
[6] 程燕妮, 樊菁, 肖瑶, 舒瑞, 明昊, 党晓智, 宋宏萍. 乳腺组织定位标记夹的应用与进展[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 361-365.
[7] 涂盛楠, 胡芬, 张娟, 蔡海峰, 杨俊泉. 天然植物提取物在乳腺癌治疗中的应用[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 366-370.
[8] 朱文婷, 顾鹏, 孙星. 非酒精性脂肪性肝病对乳腺癌发生发展及治疗的影响[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 371-375.
[9] 周荷妹, 金杰, 叶建东, 夏之一, 王进进, 丁宁. 罕见成人肋骨郎格汉斯细胞组织细胞增生症被误诊为乳腺癌术后骨转移一例[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 380-383.
[10] 葛睿, 陈飞, 李杰, 李娟娟, 陈涵. 多基因检测在早期乳腺癌辅助治疗中的应用价值[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(05): 257-263.
[11] 韩萌萌, 冯雪园, 马宁. 乳腺癌改良根治术后桡神经损伤1例[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 117-118.
[12] 高杰红, 黎平平, 齐婧, 代引海. ETFA和CD34在乳腺癌中的表达及与临床病理参数和预后的关系研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 64-67.
[13] 张志兆, 王睿, 郜苹苹, 王成方, 王成, 齐晓伟. DNMT3B与乳腺癌预后的关系及其生物学机制[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 624-629.
[14] 王玲艳, 高春晖, 冯雪园, 崔鑫淼, 刘欢, 赵文明, 张金库. 循环肿瘤细胞在乳腺癌新辅助及术后辅助治疗中的应用[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 630-633.
[15] 赵林娟, 吕婕, 王文胜, 马德茂, 侯涛. 超声引导下染色剂标记切缘的梭柱型和圆柱型保乳区段切除术的效果研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 634-637.
阅读次数
全文


摘要